Translational Session
A to X Nephrology Hot Topics: Autoantibodies, Clazakizumab, Semaglutide (FLOW), and Xenotransplantation
October 25, 2024 | 02:00 PM - 04:00 PM
Location: Ballroom 20A, Convention Center
Session Description
This special session serves as a forum for the nephrology community to learn about recent advances in our field. Learn about new findings in glomerular diseases, hemodialysis, diabetic kidney disease, and transplantation.
Microphones will not be available during Q&A periods in this session. Please click here to submit your questions during the session.
Learning Objective(s)
- Describe the role of antinephrin autoantibodies in nephrotic syndrome
- Discuss effects of anti-inflammatory medication in patients undergoing hemodialysis
- Discuss effects of semaglutide in patients with diabetic CKD
- Describe advances in xenotransplanation
Learning Pathway(s)
- Diabetic Kidney Disease
- Kidney Transplantation
Moderators
Presentations
- Autoantibodies Targeting Nephrin in Podocytopathies
02:00 PM - 02:30 PM
- IL-6 Inhibition with Clazakizumab in Patients Receiving Maintenance Dialysis
02:30 PM - 03:00 PM
- Effects of Semaglutide on CKD in Patients with Type 2 Diabetes (FLOW)
03:00 PM - 03:30 PM
- Genetically Edited Pig-to-Human Kidney Transplantation
03:30 PM - 04:00 PM